C. Michael Pearson, Former Valeant Chief, to Receive Million Severance
Mr. Pearson stepped down amid a series of investigations into Valeant’s business practices.
Showing posts with label Valeant. Show all posts
Showing posts with label Valeant. Show all posts
Tuesday, May 31, 2016
Friday, April 29, 2016
Valeant Files Annual Report, Says in Compliance With Covenants
Valeant Files Annual Report, Says in Compliance With Covenants
Beleaguered Canadian drugmaker Valeant Pharmaceuticals International Inc filed its long-delayed 2015 annual report on Friday, and said it was in compliance with its credit agreement and senior note indentures.
Tuesday, April 5, 2016
Compensation: Valeant Is a Reminder of the Peril of Outsize Executive Pay
Compensation: Valeant Is a Reminder of the Peril of Outsize Executive Pay
Compensation based largely on stock price performance probably played a role in the behavior that led to the drug company’s rise and stunning fall.
Tuesday, November 10, 2015
Ackman Defends Pershing’s Valeant Losses and Digs at ‘Snide Comments’
Ackman Defends Pershing’s Valeant Losses and Digs at ‘Snide Comments’
William A. Ackman held an investor conference call during which he criticized those betting against him and Pershing Square Capital Management, his $ 16.5 billion hedge firm.
News: Morning Agenda: Ackman Defiant Over Valeant
News: Morning Agenda: Ackman Defiant Over Valeant
Pimco Suit Highlights Murky Investor Fees | Canadian Pacific Said to Weigh Norfolk Southern Deal | Match Seeks $ 3.1 Billion Valuation
Friday, October 30, 2015
Valeant Drops Philidor Mail-Order Pharmacy
Valeant Drops Philidor Mail-Order Pharmacy
The drug maker had been criticized for recommending Philidor Rx Services because it discouraged the prescription of less-expensive medicines.
Morning Agenda: Valeant Drops Philidor
Morning Agenda: Valeant Drops Philidor
Deal-Making Frenzy in the Health Care Sector | The Long Shadow of European Banks | RushCard to Reimburse Customers
Valeant Drops Use of Mail-Order Pharmacy
Valeant Drops Use of Mail-Order Pharmacy
The drug maker had been criticized for recommending Philidor Rx Services because it discouraged the prescription of less-expensive medicines.
Tuesday, October 27, 2015
Is Valeant Pharmaceuticals the Next Enron?
Is Valeant Pharmaceuticals the Next Enron?
Allegations about Valeant’s practices and its own disclosures while under pressure cause one to wonder.
Thursday, October 22, 2015
News: Morning Agenda: Valeant Plunges on Fraud Claim
News: Morning Agenda: Valeant Plunges on Fraud Claim
Obama Administration Draws Up Debt Plan for Puerto Rico | John Thain of CIT Group to Step Down as Chief
Subscribe to:
Posts (Atom)